mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
AP-24534 |
FIMM |
pan-cancer |
AAC |
-0.1 |
0.6 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.7 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.7 |